Publications 2023

Oender D, Faber J, Wilke C, Schaprian T, Lakghomi A, Mengel D, Schöls L, Traschütz A, Fleszar Z, Dufke C, Vielhaber S, Machts J, Giordano I, Grobe-Einsler M, Klopstock T, Stendel C, Boesch S, Nachbauer W, Timmann-Braun D, Thieme AG, Kamm C, Dudesek A, Tallaksen C, Wedding I, Filla A et al. (2023)
Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult-Onset Degenerative Ataxia
Mov Disord, 38 (4), 654-664
DOI 10.1002/mds.29324, PubMed 36695111

Publications 2021

Tallaksen C, Narverud SF (2021)
[Shoshin beriberi]
Tidsskr Nor Laegeforen, 141 (6)
DOI 10.4045/tidsskr.21.0215, PubMed 33876616

Publications 2020

Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CM, Brodtkorb E, Ostergaard E, de Coo IFM, Pias-Peleteiro L, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA (2020)
Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases
J Inherit Metab Dis, 43 (4), 726-736
DOI 10.1002/jimd.12211, PubMed 32391929

Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CME, Samsonsen C, Brodtkorb E, Ostergaard E, de Coo R, Pias-Peleteiro L, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA (2020)
The impact of gender, puberty, and pregnancy in patients with POLG disease
Ann Clin Transl Neurol, 7 (10), 2019-2025
DOI 10.1002/acn3.51199, PubMed 32949115

Hikmat O, Vederhus BJ, Benestad MR, Engeset IME, Klingenberg C, Rasmussen M, Tallaksen CM, Brodtkorb E, Elgen IB, Bindoff LA (2020)
Mental health and health related quality of life in mitochondrial POLG disease
Mitochondrion, 55, 95-99
DOI 10.1016/j.mito.2020.09.005, PubMed 32976988

Prestsæter S, Koht J, Lamari F, Tallaksen CME, Hoven STJ, Vigeland MD, Selmer KK, Rydning SL (2020)
Elevated hydroxycholesterols in Norwegian patients with hereditary spastic paraplegia SPG5
J Neurol Sci, 419, 117211
DOI 10.1016/j.jns.2020.117211, PubMed 33160247

Publications 2019

Lipka AF, Boldingh MI, van Zwet EW, Schreurs MWJ, Kuks JBM, Tallaksen CM, Titulaer MJ, Verschuuren JJGM (2019)
Long-term follow-up, quality of life, and survival of patients with Lambert-Eaton myasthenic syndrome
Neurology, 94 (5), e511-e520
DOI 10.1212/WNL.0000000000008747, PubMed 31831596

Rydning SL, Koht J, Sheng Y, Sowa P, Hjorthaug HS, Wedding IM, Erichsen AK, Hovden IA, Backe PH, Tallaksen CME, Vigeland MD, Selmer KK (2019)
Biallelic POLR3A variants confirmed as a frequent cause of hereditary ataxia and spastic paraparesis
Brain, 142 (4), e12
DOI 10.1093/brain/awz041, PubMed 30847471

Stenshorne I, Rasmussen M, Salvanos P, Tallaksen CME, Bindoff LA, Koht J (2019)
Fever-related ataxia: a case report of CAPOS syndrome
Cerebellum Ataxias, 6, 2
DOI 10.1186/s40673-019-0096-3, PubMed 31410291

Publications 2018

Arntzen KA, Høyer H, Ørstavik K, Tallaksen C, Vedeler C, Østern R, Nebuchennykh M, Braathen GJ, Fagerheim T (2018)
Charcot-Marie-Tooth disease type 4C in Norway: Clinical characteristics, mutation spectrum and minimum prevalence
Neuromuscul Disord, 28 (8), 639-645
DOI 10.1016/j.nmd.2018.06.004, PubMed 30001926

Coutelier M, Hammer MB, Stevanin G, Monin ML, Davoine CS, Mochel F, Labauge P, Ewenczyk C, Ding J, Gibbs JR, Hannequin D, Melki J, Toutain A, Laugel V, Forlani S, Charles P, Broussolle E, Thobois S, Afenjar A, Anheim M, Calvas P, Castelnovo G, de Broucker T, Vidailhet M, Moulignier A et al. (2018)
Efficacy of Exome-Targeted Capture Sequencing to Detect Mutations in Known Cerebellar Ataxia Genes
JAMA Neurol, 75 (5), 591-599
DOI 10.1001/jamaneurol.2017.5121, PubMed 29482223

Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA (2018)
Elevated cerebrospinal fluid protein in POLG-related epilepsy: Diagnostic and prognostic implications
Epilepsia, 59 (8), 1595-1602
DOI 10.1111/epi.14459, PubMed 29920680

Hikmat O, Tzoulis C, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, McFarland R, Rahman S, Bindoff LA (2018)
Erratum to: The presence of anaemia negatively influences survival in patients with POLG disease
J Inherit Metab Dis, 41 (1), 153
DOI 10.1007/s10545-017-0092-9, PubMed 28952135

Parodi L, Fenu S, Barbier M, Banneau G, Duyckaerts C, Tezenas du Montcel S, Monin ML, Ait Said S, Guegan J, Tallaksen CME, Sablonniere B, Brice A, Stevanin G, Depienne C, Durr A, SPATAX network (2018)
Spastic paraplegia due to SPAST mutations is modified by the underlying mutation and sex
Brain, 141 (12), 3331-3342
DOI 10.1093/brain/awy285, PubMed 30476002

Rydning SL, Dudesek A, Rimmele F, Funke C, Krüger S, Biskup S, Vigeland MD, Hjorthaug HS, Sejersted Y, Tallaksen C, Selmer KK, Kamm C (2018)
A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia
Eur J Neurol, 25 (7), 943-e71
DOI 10.1111/ene.13625, PubMed 29528531

Samuelsson K, Radovic A, Press R, Auranen M, Ylikallio E, Tyynismaa H, KäRppä M, Veteläinen M, Peltola N, Mellgren SI, Mygland Å, Tallaksen C, Andersen H, Terkelsen AJ, Fontain F, Hietaharju A (2018)
Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathy
Muscle Nerve, 59 (3), 354-357
DOI 10.1002/mus.26348, PubMed 30246259

Sjaastad O, Blau N, Rydning SL, Peters V, Rødningen O, Stray-Pedersen A, Krossnes B, Tallaksen C, Koht J (2018)
Homocarnosinosis: A historical update and findings in the SPG11 gene
Acta Neurol Scand, 138 (3), 245-250
DOI 10.1111/ane.12949, PubMed 29732542

Publications 2017

Boldingh MI, Maniaol A, Brunborg C, Dekker L, Lipka A, Niks EH, Verschuuren J, Tallaksen C (2017)
Prevalence and clinical aspects of immigrants with myasthenia gravis in northern Europe
Muscle Nerve, 55 (6), 819-827
DOI 10.1002/mus.25408, PubMed 27641227

Giordano I, Harmuth F, Jacobi H, Paap B, Vielhaber S, Machts J, Schöls L, Synofzik M, Sturm M, Tallaksen C, Wedding IM, Boesch S, Eigentler A, van de Warrenburg B, van Gaalen J, Kamm C, Dudesek A, Kang JS, Timmann D, Silvestri G, Masciullo M, Klopstock T, Neuhofer C, Ganos C, Filla A et al. (2017)
Clinical and genetic characteristics of sporadic adult-onset degenerative ataxia
Neurology, 89 (10), 1043-1049
DOI 10.1212/WNL.0000000000004311, PubMed 28794257

Hikmat O, Tzoulis C, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, McFarland R, Rahman S, Bindoff LA (2017)
The presence of anaemia negatively influences survival in patients with POLG disease
J Inherit Metab Dis, 40 (6), 861-866
DOI 10.1007/s10545-017-0084-9, PubMed 28865037

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CM, Toft M (2017)
Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
PLoS One, 12 (3), e0174667
DOI 10.1371/journal.pone.0174667, PubMed 28362824

Iqbal Z, Rydning SL, Wedding IM, Koht J, Pihlstrøm L, Rengmark AH, Henriksen SP, Tallaksen CME, Toft M (2017)
Correction: Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia
PLoS One, 12 (10), e0186571
DOI 10.1371/journal.pone.0186571, PubMed 29023604

Rydning SL, Backe PH, Sousa MML, Iqbal Z, Øye AM, Sheng Y, Yang M, Lin X, Slupphaug G, Nordenmark TH, Vigeland MD, Bjørås M, Tallaksen CM, Selmer KK (2017)
Novel UCHL1 mutations reveal new insights into ubiquitin processing
Hum Mol Genet, 26 (6), 1031-1040
DOI 10.1093/hmg/ddw391, PubMed 28007905

Rydning SL, Backe PH, Sousa MML, Iqbal Z, Øye AM, Sheng Y, Yang M, Lin X, Slupphaug G, Nordenmark TH, Vigeland MD, Bjørås M, Tallaksen CM, Selmer KK (2017)
Novel UCHL1 mutations reveal new insights into ubiquitin processing
Hum Mol Genet, 26 (6), 1217-1218
DOI 10.1093/hmg/ddx072, PubMed 28334853

Tallaksen CM, Müller U (2017)
Cancer and neurodegeneration: Time to move beyond Janus?
Neurology, 88 (12), 1106-1107
DOI 10.1212/WNL.0000000000003727, PubMed 28202693

Publications 2016

Boldingh MI, Maniaol AH, Brunborg C, Weedon-Fekjær H, Verschuuren JJ, Tallaksen CM (2016)
Increased risk for clinical onset of myasthenia gravis during the postpartum period
Neurology, 87 (20), 2139-2145
DOI 10.1212/WNL.0000000000003339, PubMed 27770065

Gilhus NE, Kerty E, Løseth S, Mygland Å, Tallaksen C (2016)
[Myasthenia gravis - optimal treatment and accurate diagnosis]
Tidsskr Nor Laegeforen, 136 (12-13), 1089-94
DOI 10.4045/tidsskr.15.1259, PubMed 27381787

Jahic A, Erichsen AK, Deufel T, Tallaksen CM, Beetz C (2016)
A polymorphic Alu insertion that mediates distinct disease-associated deletions
Eur J Hum Genet, 24 (9), 1371-4
DOI 10.1038/ejhg.2016.20, PubMed 26932189

Koht J, Løstegaard SO, Wedding I, Vidailhet M, Louha M, Tallaksen CM (2016)
Benign hereditary chorea, not only chorea: a family case presentation
Cerebellum Ataxias, 3, 3
DOI 10.1186/s40673-016-0041-7, PubMed 26839702

Paap BK, Roeske S, Durr A, Schöls L, Ashizawa T, Boesch S, Bunn LM, Delatycki MB, Giunti P, Lehéricy S, Mariotti C, Melegh J, Pandolfo M, Tallaksen CME, Timmann D, Tsuji S, Schulz JB, van de Warrenburg BP, Klockgether T (2016)
Standardized Assessment of Hereditary Ataxia Patients in Clinical Studies
Mov Disord Clin Pract, 3 (3), 230-240
DOI 10.1002/mdc3.12315, PubMed 30363623

Rydning SL, Wedding IM, Koht J, Chawla M, Øye AM, Sheng Y, Vigeland MD, Selmer KK, Tallaksen CM (2016)
A founder mutation p.H701P identified as a major cause of SPG7 in Norway
Eur J Neurol, 23 (4), 763-71
DOI 10.1111/ene.12937, PubMed 26756429

Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
BMC Neurol, 16 (1), 252
DOI 10.1186/s12883-016-0771-4, PubMed 27919248

Stergiou C, Lazaridis K, Zouvelou V, Tzartos J, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B et al. (2016)
Titin antibodies in "seronegative" myasthenia gravis--A new role for an old antigen
J Neuroimmunol, 292, 108-15
DOI 10.1016/j.jneuroim.2016.01.018, PubMed 26943968

Publications 2015

Boldingh MI, Dekker L, Maniaol AH, Brunborg C, Lipka AF, Niks EH, Verschuuren JJ, Tallaksen CM (2015)
An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts
Health Qual Life Outcomes, 13, 115
DOI 10.1186/s12955-015-0298-1, PubMed 26232146

Boldingh MI, Maniaol AH, Brunborg C, Dekker L, Heldal AT, Lipka AF, Popperud TH, Niks EH, Verschuuren JJ, Tallaksen CM (2015)
Geographical Distribution of Myasthenia Gravis in Northern Europe--Results from a Population-Based Study from Two Countries
Neuroepidemiology, 44 (4), 221-31
DOI 10.1159/000431036, PubMed 26068011

Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM et al. (2015)
Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia
Brain, 138 (Pt 8), 2191-205
DOI 10.1093/brain/awv143, PubMed 26026163

Horn MA, Mikaelsen KB, Ferdinandusse S, Jørum E, Mellgren SI, Retterstøl L, Wanders RJ, Tallaksen CM (2015)
Mild phenotype in an adult male with X-linked adrenoleukodystrophy - case report
Clin Case Rep, 4 (2), 177-81
DOI 10.1002/ccr3.434, PubMed 26862418

Monin ML, Tezenas du Montcel S, Marelli C, Cazeneuve C, Charles P, Tallaksen C, Forlani S, Stevanin G, Brice A, Durr A (2015)
Survival and severity in dominant cerebellar ataxias
Ann Clin Transl Neurol, 2 (2), 202-7
DOI 10.1002/acn3.156, PubMed 25750924

Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Behin A, Sharshar T, De Baets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A et al. (2015)
MuSK autoantibodies in myasthenia gravis detected by cell based assay--A multinational study
J Neuroimmunol, 284, 10-7
DOI 10.1016/j.jneuroim.2015.04.015, PubMed 26025053

Wedding IM, Kroken M, Henriksen SP, Selmer KK, Fiskerstrand T, Knappskog PM, Berge T, Tallaksen CM (2015)
Friedreich ataxia in Norway - an epidemiological, molecular and clinical study
Orphanet J Rare Dis, 10, 108
DOI 10.1186/s13023-015-0328-4, PubMed 26338206

Publications 2014

Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C et al. (2014)
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
Ann Clin Transl Neurol, 1 (5), 329-39
DOI 10.1002/acn3.51, PubMed 25356403

Heimdal K, Sanchez-Guixé M, Aukrust I, Bollerslev J, Bruland O, Jablonski GE, Erichsen AK, Gude E, Koht JA, Erdal S, Fiskerstrand T, Haukanes BI, Boman H, Bjørkhaug L, Tallaksen CM, Knappskog PM, Johansson S (2014)
STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity
Orphanet J Rare Dis, 9, 146
DOI 10.1186/s13023-014-0146-0, PubMed 25258038

Horn MA, Nilsen KB, Jørum E, Mellgren SI, Tallaksen CM (2014)
Small nerve fiber involvement is frequent in X-linked adrenoleukodystrophy
Neurology, 82 (19), 1678-83
DOI 10.1212/WNL.0000000000000415, PubMed 24719486

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2014)
Age-dependent penetrance among females with X-linked adrenoleukodystrophy
Brain, 138 (Pt 2), e325
DOI 10.1093/brain/awu232, PubMed 25149409

Koht J, Rengmark A, Opladen T, Bjørnarå KA, Selberg T, Tallaksen CM, Blau N, Toft M (2014)
Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene
Acta Neurol Scand Suppl (198), 7-12
DOI 10.1111/ane.12230, PubMed 24588500

Wedding IM, Koht J, Tran GT, Misceo D, Selmer KK, Holmgren A, Frengen E, Bindoff L, Tallaksen CM, Tzoulis C (2014)
Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions
PLoS One, 9 (1), e86340
DOI 10.1371/journal.pone.0086340, PubMed 24466038

Publications 2013

Horn MA, Erichsen MM, Wolff AS, Månsson JE, Husebye ES, Tallaksen CM, Skjeldal OH (2013)
Screening for X-linked adrenoleukodystrophy among adult men with Addison's disease
Clin Endocrinol (Oxf), 79 (3), 316-20
DOI 10.1111/cen.12159, PubMed 23346902

Horn MA, Retterstøl L, Abdelnoor M, Skjeldal OH, Tallaksen CM (2013)
Adrenoleukodystrophy in Norway: high rate of de novo mutations and age-dependent penetrance
Pediatr Neurol, 48 (3), 212-9
DOI 10.1016/j.pediatrneurol.2012.12.007, PubMed 23419472

Sumathipala DS, Abeysekera GS, Jayasekara RW, Tallaksen CM, Dissanayake VH (2013)
Autosomal dominant hereditary ataxia in Sri Lanka
BMC Neurol, 13, 39
DOI 10.1186/1471-2377-13-39, PubMed 23634774

Wedding IM, Koht J, Dietrichs E, Landrø NI, Tallaksen CM (2013)
Cognition is only minimally impaired in Spinocerebellar ataxia type 14 (SCA14): a neuropsychological study of ten Norwegian subjects compared to intrafamilial controls and population norm
BMC Neurol, 13, 186
DOI 10.1186/1471-2377-13-186, PubMed 24289098

Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P et al. (2013)
A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
J Autoimmun, 52, 139-45
DOI 10.1016/j.jaut.2013.12.004, PubMed 24373505

Publications 2012

Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A et al. (2012)
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08
Ann Neurol, 72 (6), 927-35
DOI 10.1002/ana.23691, PubMed 23055271

Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CME (2012)
Smoking and socio-economic status may affect myasthenia gravis
Eur J Neurol, 20 (3), 453-460
DOI 10.1111/j.1468-1331.2012.03843.x, PubMed 22934661

Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012)
Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population
PLoS One, 7 (5), e36603
DOI 10.1371/journal.pone.0036603, PubMed 22590574

Tezenas du Montcel S, Charles P, Goizet C, Marelli C, Ribai P, Vincitorio C, Anheim M, Guyant-Maréchal L, Le Bayon A, Vandenberghe N, Tchikviladzé M, Devos D, Le Ber I, N'Guyen K, Cazeneuve C, Tallaksen C, Brice A, Durr A (2012)
Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia
Arch Neurol, 69 (4), 500-8
DOI 10.1001/archneurol.2011.2713, PubMed 22491195

Publications 2011

Alseth EH, Maniaol AH, Elsais A, Nakkestad HL, Tallaksen C, Gilhus NE, Skeie GO (2011)
Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients
Muscle Nerve, 43 (4), 574-7
DOI 10.1002/mus.21919, PubMed 21305573

Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J (2011)
EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders
Eur J Neurol, 18 (2), 207-217
DOI 10.1111/j.1468-1331.2010.03069.x, PubMed 20500522

Holmøy T, Braaten Ø, Hovden IA, Tallaksen CM (2011)
[A young woman with a weakening leg]
Tidsskr Nor Laegeforen, 131 (6), 583-6
DOI 10.4045/tidsskr.09.1499, PubMed 21423311

Koht J, Stevanin G, Durr A, Mundwiller E, Brice A, Tallaksen CM (2011)
SCA14 in Norway, two families with autosomal dominant cerebellar ataxia and a novel mutation in the PRKCG gene
Acta Neurol Scand, 125 (2), 116-22
DOI 10.1111/j.1600-0404.2011.01504.x, PubMed 21434874

Publications 2010

Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T, EFNS (2010)
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias
Eur J Neurol, 17 (5), 641-8
DOI 10.1111/j.1468-1331.2010.02985.x, PubMed 20298421

Maniaol AH, Brunborg C, Tallaksen CM (2010)
Development and validation of a self-administered questionnaire for myasthenia gravis patients
Neuroepidemiology, 34 (4), 253-61
DOI 10.1159/000297753, PubMed 20299807

Schlipf NA, Beetz C, Schüle R, Stevanin G, Erichsen AK, Forlani S, Zaros C, Karle K, Klebe S, Klimpe S, Durr A, Otto S, Tallaksen CM, Riess O, Brice A, Bauer P, Schöls L (2010)
A total of 220 patients with autosomal dominant spastic paraplegia do not display mutations in the SLC33A1 gene (SPG42)
Eur J Hum Genet, 18 (9), 1065-7
DOI 10.1038/ejhg.2010.68, PubMed 20461110

Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, Auer-Grumbach M, Toscano A, Musumeci O, Valentino ML, Caporali L, Lamperti C, Tallaksen CM, Duffey P, Miller J, Whittaker RG, Baker MR, Jackson MJ, Clarke MP, Dhillon B, Czermin B, Stewart JD, Hudson G, Reynier P, Bonneau D, Marques W et al. (2010)
Multi-system neurological disease is common in patients with OPA1 mutations
Brain, 133 (Pt 3), 771-86
DOI 10.1093/brain/awq007, PubMed 20157015

Publications 2009

Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM (2009)
Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study
Brain, 132 (Pt 6), 1577-88
DOI 10.1093/brain/awp056, PubMed 19339254

Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Gasser T, European Federation of Neurological Sciences (2009)
EFNS guidelines on the molecular diagnosis of mitochondrial disorders
Eur J Neurol, 16 (12), 1255-64
DOI 10.1111/j.1468-1331.2009.02811.x, PubMed 19950421

Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Harbo HF, EFNS (2009)
EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias
Eur J Neurol, 17 (2), 179-88
DOI 10.1111/j.1468-1331.2009.02873.x, PubMed 20050888

Goizet C, Boukhris A, Mundwiller E, Tallaksen C, Forlani S, Toutain A, Carriere N, Paquis V, Depienne C, Durr A, Stevanin G, Brice A (2009)
Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10
Hum Mutat, 30 (2), E376-85
DOI 10.1002/humu.20920, PubMed 18853458

Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T, EFNS (2009)
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias
Eur J Neurol, 16 (7), 777-85
DOI 10.1111/j.1468-1331.2009.02646.x, PubMed 19469830

Koht J, Bjørnarå KA, Jørum E, Tallaksen CM (2009)
Ataxia with vitamin E deficiency in southeast Norway, case report
Acta Neurol Scand Suppl (189), 42-5
DOI 10.1111/j.1600-0404.2009.01214.x, PubMed 19566498

Selmer KK, Eriksson AS, Brandal K, Egeland T, Tallaksen C, Undlien DE (2009)
Parental SCN1A mutation mosaicism in familial Dravet syndrome
Clin Genet, 76 (4), 398-403
DOI 10.1111/j.1399-0004.2009.01208.x, PubMed 19673951

Tallaksen CM, Berg JE (2009)
Miglustat therapy in juvenile Sandhoff disease
J Inherit Metab Dis, 32 Suppl 1, S289-93
DOI 10.1007/s10545-009-1224-7, PubMed 19898953

Vevelstad M, Pettersen S, Tallaksen C, Brørs O (2009)
O-demethylation of codeine to morphine inhibited by low-dose levomepromazine
Eur J Clin Pharmacol, 65 (8), 795-801
DOI 10.1007/s00228-009-0640-9, PubMed 19308365

Publications 2008

Erichsen AK, Server A, Landrø NI, Sandvik L, Tallaksen CM (2008)
Proton magnetic resonance spectroscopy and cognition in patients with spastin mutations
J Neurol Sci, 277 (1-2), 124-9
DOI 10.1016/j.jns.2008.10.030, PubMed 19084842

Erichsen AK, Stevanin G, Denora P, Brice A, Tallaksen CM (2008)
SPG11--the most common type of recessive spastic paraplegia in Norway?
Acta Neurol Scand Suppl, 188, 46-50
DOI 10.1111/j.1600-0404.2008.01031.x, PubMed 18439221

Tallaksen CM (2008)
[Hereditary ataxias]
Tidsskr Nor Laegeforen, 128 (17), 1977-80
PubMed 18787576

Publications 2007

Erichsen AK, Inderhaug E, Mattingsdal M, Eiklid K, Tallaksen CM (2007)
Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia
Eur J Neurol, 14 (7), 809-14
DOI 10.1111/j.1468-1331.2007.01861.x, PubMed 17594340

Horn MA, van den Brink DM, Wanders RJ, Duran M, Poll-The BT, Tallaksen CM, Stokke OH, Moser H, Skjeldal OH (2007)
Phenotype of adult Refsum disease due to a defect in peroxin 7
Neurology, 68 (9), 698-700
DOI 10.1212/01.wnl.0000255960.01644.39, PubMed 17325280

Koht J, Tallaksen CM (2007)
Cerebellar ataxia in the eastern and southern parts of Norway
Acta Neurol Scand Suppl, 187, 76-9
DOI 10.1111/j.1600-0404.2007.00853.x, PubMed 17419835

Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A, Rosa AL, Lerer I, Hamri A, Alegria P, Loureiro J, Tada M, Hannequin D, Anheim M, Goizet C, Gonzalez-Martinez V, Le Ber I, Forlani S, Iwabuchi K, Meiner V, Uyanik G, Erichsen AK, Feki I, Pasquier F, Belarbi S et al. (2007)
Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration
Brain, 131 (Pt 3), 772-84
DOI 10.1093/brain/awm293, PubMed 18079167

Publications 2006

Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribaï P, Feki I, Tallaksen C, Nguyen K, Stankoff B, Ruberg M, Stevanin G, Durr A, Brice A (2006)
Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia
J Med Genet, 44 (4), 281-4
DOI 10.1136/jmg.2006.046425, PubMed 17098887

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0555
Hum Genet, 118 (6), 782
PubMed 17297711

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hs0516
Hum Genet, 118 (6), 785
PubMed 17297722

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hd0519
Hum Genet, 118 (6), 776
PubMed 17297686

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST (SPG4). Disease: Spastic paraparesis. Accession #Hm0552
Hum Genet, 118 (6), 781
PubMed 17297708

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0553
Hum Genet, 118 (6), 782
PubMed 17297709

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0554
Hum Genet, 118 (6), 782
PubMed 17297710

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0556
Hum Genet, 118 (6), 782
PubMed 17297712

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: Spastic paraparesis. Accession #Hm0557
Hum Genet, 118 (6), 783
PubMed 17297713

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006)
Gene symbol: SPAST. Disease: spastic paraparesis. Accession #Hs0515
Hum Genet, 118 (6), 785
PubMed 17297721

Elleuch N, Depienne C, Benomar A, Hernandez AM, Ferrer X, Fontaine B, Grid D, Tallaksen CM, Zemmouri R, Stevanin G, Durr A, Brice A (2006)
Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia
Neurology, 66 (5), 654-9
DOI 10.1212/01.wnl.0000201185.91110.15, PubMed 16534102

Meraouna A, Cizeron-Clairac G, Panse RL, Bismuth J, Truffault F, Tallaksen C, Berrih-Aknin S (2006)
The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis
Blood, 108 (2), 432-40
DOI 10.1182/blood-2005-06-2383, PubMed 16543475

Publications 2005

Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2005)
Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases
J Med Genet, 43 (3), 259-65
DOI 10.1136/jmg.2005.035311, PubMed 16055926

Publications 2004

Dietrichs E, Tallaksen CM (2004)
[Genetics in movement disorders--dystonia, tremor and chorea]
Tidsskr Nor Laegeforen, 124 (17), 2236-7
PubMed 15356687

Dürr A, Camuzat A, Colin E, Tallaksen C, Hannequin D, Coutinho P, Fontaine B, Rossi A, Gil R, Rousselle C, Ruberg M, Stevanin G, Brice A (2004)
Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia
Arch Neurol, 61 (12), 1867-72
DOI 10.1001/archneur.61.12.1867, PubMed 15596607

Tallaksen CM, Dietrichs E (2004)
[The genetics of movement disorders--spinocerebellar degenerations]
Tidsskr Nor Laegeforen, 124 (17), 2233-5
PubMed 15356686

Publications 2003

Tallaksen CM, Guichart-Gomez E, Verpillat P, Hahn-Barma V, Ruberg M, Fontaine B, Brice A, Dubois B, Durr A (2003)
Subtle cognitive impairment but no dementia in patients with spastin mutations
Arch Neurol, 60 (8), 1113-8
DOI 10.1001/archneur.60.8.1113, PubMed 12925368

Publications 2002

Jacquemont ML, Campion D, Hahn V, Tallaksen C, Frebourg T, Brice A, Durr A (2002)
Spastic paraparesis and atypical dementia caused by PSEN1 mutation (P264L), responsible for Alzheimer's disease
J Med Genet, 39 (2), E2
DOI 10.1136/jmg.39.2.e2, PubMed 11836371

Publications 2001

Tallaksen CM, Dürr A, Brice A (2001)
Recent advances in hereditary spastic paraplegia
Curr Opin Neurol, 14 (4), 457-63
DOI 10.1097/00019052-200108000-00005, PubMed 11470961

Publications 2000

Tallaksen CM, Taubøll E (2000)
Excitatory effect of thiamin on CA1 pyramidal neurones in rat hippocampal slices in vitro
Eur J Neurol, 7 (6), 693-8
DOI 10.1046/j.1468-1331.2000.00132.x, PubMed 11136357

Publications 1999

Tallaksen CM, Taubøll E, Nome T (1999)
[Normal pressure hydrocephalus--evaluation of investigation procedures]
Tidsskr Nor Laegeforen, 119 (12), 1744-9
PubMed 10380589

Publications 1998

Tallaksen CM, Bovim G (1998)
[Thiamine treatment today]
Tidsskr Nor Laegeforen, 118 (25), 3946-9
PubMed 9830340

Publications 1997

Tallaksen CM, Bøhmer T, Karlsen J, Bell H (1997)
Determination of thiamin and its phosphate esters in human blood, plasma, and urine
Methods Enzymol, 279, 67-74
DOI 10.1016/s0076-6879(97)79010-4, PubMed 9211258

Tallaksen CM, Jetne V, Fosså S (1997)
Postradiation lower motor neuron syndrome--a case report and brief literature review
Acta Oncol, 36 (3), 345-7
DOI 10.3109/02841869709001276, PubMed 9208910

Publications 1994

Bell H, Tallaksen CM, Try K, Haug E (1994)
Carbohydrate-deficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department
Alcohol Clin Exp Res, 18 (5), 1103-8
DOI 10.1111/j.1530-0277.1994.tb00088.x, PubMed 7847591

Bøhmer T, Utzon P, Tallaksen C (1994)
[Scurvy with simultaneous wet beriberi in 2 patients]
Tidsskr Nor Laegeforen, 114 (27), 3181-3
PubMed 7809869

Tallaksen CM, Bell H, Bøhmer T (1994)
Elevated plasma thiamin concentrations in patients with rhabdomyolysis
Clin Nutr, 13 (2), 123-4
DOI 10.1016/0261-5614(94)90071-x, PubMed 16843371

Publications 1993

Bell H, Tallaksen C, Sjåheim T, Weberg R, Raknerud N, Orjasaeter H, Try K, Haug E (1993)
Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases
Alcohol Clin Exp Res, 17 (2), 246-52
DOI 10.1111/j.1530-0277.1993.tb00757.x, PubMed 8488962

Tallaksen CM, Bell H, Bøhmer T (1993)
Thiamin and thiamin phosphate ester deficiency assessed by high performance liquid chromatography in four clinical cases of Wernicke encephalopathy
Alcohol Clin Exp Res, 17 (3), 712-6
DOI 10.1111/j.1530-0277.1993.tb00825.x, PubMed 8333605

Tallaksen CM, Sande A, Bøhmer T, Bell H, Karlsen J (1993)
Kinetics of thiamin and thiamin phosphate esters in human blood, plasma and urine after 50 mg intravenously or orally
Eur J Clin Pharmacol, 44 (1), 73-8
DOI 10.1007/BF00315284, PubMed 8436160

Publications 1992

Tallaksen CM, Bell H, Bøhmer T (1992)
The concentration of thiamin and thiamin phosphate esters in patients with alcoholic liver cirrhosis
Alcohol Alcohol, 27 (5), 523-30
PubMed 1476555

Tallaksen CM, Bøhmer T, Bell H (1992)
Blood and serum thiamin and thiamin phosphate esters concentrations in patients with alcohol dependence syndrome before and after thiamin treatment
Alcohol Clin Exp Res, 16 (2), 320-5
DOI 10.1111/j.1530-0277.1992.tb01384.x, PubMed 1317136

Tallaksen CM, Bøhmer T, Bell H (1992)
Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals
Am J Clin Nutr, 56 (3), 559-64
DOI 10.1093/ajcn/56.3.559, PubMed 1503069

Tallaksen CME (1992)
The concentrations of thiamin and thiamin phosphate esters in patients with alcohol dependence syndrome, and in reference populations
[C.M.E. Tallaksen], Oslo, 1 b. (flere pag.)
BIBSYS 932200540, ISBN 82-992893-0-0

Publications 1991

Tallaksen CM, Bøhmer T, Bell H, Karlsen J (1991)
Concomitant determination of thiamin and its phosphate esters in human blood and serum by high-performance liquid chromatography
J Chromatogr, 564 (1), 127-36
DOI 10.1016/0378-4347(91)80075-n, PubMed 1860908